Chemours agreed to pay $455 million over 15 years to settle PFAS contamination claims at its Fayetteville Works plant. The settlement includes a $135 million reserve fund from DuPont to ensure payment
Chemours shares rose 5.4% despite three Wall Street firms cutting price targets, with JP Morgan maintaining a Neutral rating. Investors appear to have factored in the downward revisions or see potenti
The U.S. government reached a $450 million settlement with Chemours Co to resolve PFAS water pollution cases across multiple states. The agreement includes civil penalties, pollution controls, and fun
Chemours agreed to a $450 million settlement with the U.S. Justice Department regarding PFAS discharges into rivers across three states. The deal marks the first comprehensive federal settlement for s
Chemours reported a Q1 2026 net loss of $29 million but issued full-year 2026 income guidance between $165 million and $225 million, though PFAS litigation remains a key challenge.
A new study by Chemours and Solstice Advanced Materials proposes cutting cumulative automotive refrigerant emissions in Europe by 50% between 2030 and 2050 via circular economy solutions like recyclin
Chemours Co shares rose 3.6% to $23.87, though GuruFocus flags the stock as 14.7% overvalued with low financial strength. Investors are advised caution due to the elevated forward P/E ratio compared t
Chemours Co. shares reached a new 52-week high of $23.20, supported by UBS raising its price target to $29 despite mixed analyst sentiment and negative net margins. The company beat EPS expectations b
Chemours Co shares surged recently, though analysis suggests the stock may be overvalued despite PFAS litigation progress. Conversely, P/S ratios indicate a potential discount compared to industry pee
Twelve Points Wealth Management LLC reduced its stake in Chemours Co by 40.6% in Q4, selling over 50,000 shares. Chemours reported strong Q4 earnings beating estimates, maintaining a consensus Hold ra
Chemours Co submitted recent SEC filings including 10-Q reports revealing a net loss due to higher SG&A expenses, along with insider transaction and institutional holding updates.
Chemours Co stock reached a 52-week high of $22.56, marking a 139% yearly gain. Analysts expect better titanium dioxide margins after a $700 million debt offering.
Chemours Co upsized its senior notes offering to $700 million from an initial $600 million. The 9.25% notes due in 2031 are scheduled to close on April 11, 2024.
Chemours director Courtney Mather was granted 1,305 deferred stock units valued at $22.03 each per an SEC Form 4 filing. This routine equity award brings her total holdings to over 7,500 units payable
Chemours is facing a class-action lawsuit in the Netherlands regarding PFAS emissions from its Dordrecht plant, initiated by a foundation representing nearby residents.
ChemBrief